254 related articles for article (PubMed ID: 31505645)
1. Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 study.
Fuller J; Dingle TC; Bull A; Shokoples S; Laverdière M; Baxter MR; Adam HJ; Karlowsky JA; Zhanel GG;
J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv48-iv54. PubMed ID: 31505645
[TBL] [Abstract][Full Text] [Related]
2. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
4. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
5. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study.
Xiao M; Sun ZY; Kang M; Guo DW; Liao K; Chen SC; Kong F; Fan X; Cheng JW; Hou X; Zhou ML; Li Y; Yu SY; Huang JJ; Wang H; Xu YC;
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743305
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.
Guo LN; Xiao M; Cao B; Qu F; Zhan YL; Hu YJ; Wang XR; Liang GW; Gu HT; Qi J; Yuan H; Min R; Wang FY; Liu LJ; Wang HB; Jiang W; Duan XG; Xu WJ; Yu YH; Su JR; Zhang JZ; Nong JQ; Liu SM; Li J; Liu JT; Yue ZG; Yang D; Guo J; Zhao R; Zhang YN; Yang XM; Liu XQ; Hsueh PR; Xu YC
Future Microbiol; 2017 Sep; 12():1075-1086. PubMed ID: 28836465
[TBL] [Abstract][Full Text] [Related]
7. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
[TBL] [Abstract][Full Text] [Related]
9. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
Pfaller MA; Jones RN; Doern GV; Sader HS; Hollis RJ; Messer SA
J Clin Microbiol; 1998 Jul; 36(7):1886-9. PubMed ID: 9650930
[TBL] [Abstract][Full Text] [Related]
10. Species distribution and antifungal susceptibility profile of Candida isolates from blood and other normally sterile foci from pediatric ICU patients in Tehran, Iran.
Mirhendi H; Charsizadeh A; Eshaghi H; Nikmanesh B; Arendrup MC
Med Mycol; 2020 Feb; 58(2):201-206. PubMed ID: 31111910
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, Malaysia.
Amran F; Aziz MN; Ibrahim HM; Atiqah NH; Parameswari S; Hafiza MR; Ifwat M
J Med Microbiol; 2011 Sep; 60(Pt 9):1312-1316. PubMed ID: 21459913
[TBL] [Abstract][Full Text] [Related]
12. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
[TBL] [Abstract][Full Text] [Related]
13. [One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?].
Turan D; Aksaray S
Mikrobiyol Bul; 2022 Jul; 56(3):493-505. PubMed ID: 35960240
[TBL] [Abstract][Full Text] [Related]
14. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
[TBL] [Abstract][Full Text] [Related]
15. Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.
De Francesco MA; Piccinelli G; Gelmi M; Gargiulo F; Ravizzola G; Pinsi G; Peroni L; Bonfanti C; Caruso A
Mycopathologia; 2017 Oct; 182(9-10):897-905. PubMed ID: 28597394
[TBL] [Abstract][Full Text] [Related]
16. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
17. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
[TBL] [Abstract][Full Text] [Related]
18. Invasive candidiasis in Pakistan: clinical characteristics, species distribution and antifungal susceptibility.
Farooqi JQ; Jabeen K; Saeed N; Iqbal N; Malik B; Lockhart SR; Zafar A; Brandt ME; Hasan R
J Med Microbiol; 2013 Feb; 62(Pt 2):259-268. PubMed ID: 23105021
[TBL] [Abstract][Full Text] [Related]
19. Distribution and antifungal susceptibility of Candida species causing nosocomial candiduria.
Ozhak-Baysan B; Ogunc D; Colak D; Ongut G; Donmez L; Vural T; Gunseren F
Med Mycol; 2012 Jul; 50(5):529-32. PubMed ID: 21988703
[TBL] [Abstract][Full Text] [Related]
20. Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.
Liu W; Tan J; Sun J; Xu Z; Li M; Yang Q; Shao H; Zhang L; Liu W; Wan Z; Cui W; Zang B; Jiang D; Fang Q; Qin B; Qin T; Li W; Guo F; Liu D; Guan X; Yu K; Qiu H; Li R;
J Antimicrob Chemother; 2014 Jan; 69(1):162-7. PubMed ID: 24004860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
